GCM Growth Senseonics Holdings, Inc., a medical technology company that develops and commercializes long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, reported its fourth quarter and full year 2020 financial results. Senseonics’ CGM systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin…
